Case Report: A case of rituximab for membranous nephropathy secondary to primary Sjogren's syndrome and literature review. [PDF]
Fu X, Gao F, Zang L, Mao N.
europepmc +1 more source
Aging is associated with impaired TFEB‐dependent autophagy in renal proximal tubular epithelial cells, leading to increased susceptibility to LPS‐induced injury and inflammation. Restoration of autophagy through TFEB activation or Tat–Beclin 1 treatment partially rescues autophagic function and confers protection against elderly sepsis‐associated acute
Yu Xiang +7 more
wiley +1 more source
Rituximab for the treatment of membranous nephropathy in a patient with ankylosing spondylitis: a case report. [PDF]
Zhong R, Su L, Li H, Zhu H, Xiao Z.
europepmc +1 more source
The CLMBM nanoparticle (NP) system demonstrates strong and targeted anti‐ROS, antiapoptotic and anti‐inflammatory properties within the pancreas, thereby inhibiting the onset and progression of type 1 diabetes. Background and Purpose The destruction of β‐cells in type 1 diabetes is driven by signalling cascades that ultimately lead to cell apoptosis ...
Huiwen Pang +9 more
wiley +1 more source
PLA2R-Positive Membranous Nephropathy and AA Amyloidosis in an Ethiopian Patient With Chronic Hepatitis B: A Case Report. [PDF]
Abreham B +4 more
europepmc +1 more source
Fn14 signalling participates in pristane‐induced murine lupus through exacerbating oxidative stress
Background and Purpose Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by oxidative stress and immune dysregulation. Fibroblast growth factor‐inducible 14 (Fn14) has been implicated in tissue injury, but its specific role in SLE pathogenesis remains unclear.
Zhu Yan +8 more
wiley +1 more source
Comparison of the efficacy of obinutuzumab versus rituximab combined with tacrolimus in the treatment of refractory membranous nephropathy. [PDF]
Zhang Y +7 more
europepmc +1 more source
MAFF Suppresses Necroptosis in Pancreatic Cancer via the GATA4‐MLKL Axis
MAFF promotes pancreatic cancer progression by acting as a transcriptional repressor of the GATA4‐MLKL axis, thereby inhibiting necroptotic cell death. This study identifies the MAFF‐GATA4‐MLKL pathway as a novel therapeutic target and a significant prognostic biomarker for pancreatic adenocarcinoma.
Xinwei Zhou +3 more
wiley +1 more source
A membranous nephropathy variant mimicking minimal change disease. [PDF]
Pan C +8 more
europepmc +1 more source
Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) promotes obstructive nephropathy progression by activating the β‐catenin signalling pathway, driving M2 macrophage polarisation, migration and fibrogenic gene expression. targeted inhibition of TREM2 thus represents a promising novel strategy against renal fibrosis.
Jia Wei +7 more
wiley +1 more source

